FDA revoked emergency use authorization for hydroxycholoroquine to treat COVID-19. The data suggests that potential benefits donot outweigh the known risks associated with its use.
FDA revoked emergency use authorization for hydroxycholoroquine to treat COVID-19. The data suggests that potential benefits donot outweigh the known risks associated with its use.